Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gilles Bang"'
Autor:
Masanori Yagi, Gilles Bang, Takahiro Tougan, Nirianne M Q Palacpac, Nobuko Arisue, Taiki Aoshi, Yoshitsugu Matsumoto, Ken J Ishii, Thomas G Egwang, Pierre Druilhe, Toshihiro Horii
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e98460 (2014)
The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we have previously shown the inhibitory effects of SE36 specific antibodies on
Externí odkaz:
https://doaj.org/article/ca039e53734d4cca984f604e67ef3563
Autor:
James S McCarthy, Joanne Marjason, Suzanne Elliott, Paul Fahey, Gilles Bang, Elissa Malkin, Eveline Tierney, Hayley Aked-Hurditch, Christopher Adda, Nadia Cross, Jack S Richards, Freya J I Fowkes, Michelle J Boyle, Carole Long, Pierre Druilhe, James G Beeson, Robin F Anders
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24413 (2011)
In a previous Phase 1/2b malaria vaccine trial testing the 3D7 isoform of the malaria vaccine candidate Merozoite surface protein 2 (MSP2), parasite densities in children were reduced by 62%. However, breakthrough parasitemias were disproportionately
Externí odkaz:
https://doaj.org/article/48362a580ee849fd841b7e69abb62ab8
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28165 (2011)
BACKGROUND: MSP3 has been shown to induce protection against malaria in African children. The characterization of a family of Plasmodium falciparum merozoite surface protein 3 (MSP3) antigens sharing a similar structural organization, simultaneously
Externí odkaz:
https://doaj.org/article/cb53ddf952c144dea1b489f30991fee3
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28165 (2011)
PLoS ONE
PLoS ONE
BACKGROUND: MSP3 has been shown to induce protection against malaria in African children. The characterization of a family of Plasmodium falciparum merozoite surface protein 3 (MSP3) antigens sharing a similar structural organization, simultaneously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32bd1310a0dc26906ee4e7d7b892e3e0
http://europepmc.org/articles/PMC3228738?pdf=render
http://europepmc.org/articles/PMC3228738?pdf=render
Autor:
Taiki Aoshi, Ken Ishii, Takahiro Tougan, Pierre Druilhe, Toshihiro Horii, Gilles Bang, Masanori Yagi, Yoshitsugu Matsumoto, Nirianne Marie Q. Palacpac, Nobuko Arisue, Thomas G. Egwang
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 6, p e98460 (2014)
PLoS ONE, Vol 9, Iss 6, p e98460 (2014)
The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we have previously shown the inhibitory effects of SE36 specific antibodies on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed147330987a83be3b7808ec51107bc4
https://doi.org/10.1371/journal.pone.0098460
https://doi.org/10.1371/journal.pone.0098460
Autor:
Gilles Bang, Jack S. Richards, James G. Beeson, Joanne Marjason, Eveline L. Tierney, James S. McCarthy, Michelle J. Boyle, Freya J. I. Fowkes, Christopher G. Adda, Suzanne L. Elliott, Hayley Aked-Hurditch, Robin F. Anders, Paul Fahey, Pierre Druilhe, Nadia Cross, Elissa Malkin, Carole A. Long
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 9, p e24413 (2011)
PLoS ONE, Vol 6, Iss 9, p e24413 (2011)
Background: In a previous Phase 1/2b malaria vaccine trial testing the 3D7 isoform of the malaria vaccine candidate Merozoite surface protein 2 (MSP2), parasite densities in children were reduced by 62%. However, breakthrough parasitemias were dispro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cef7ade2eeb124f90e4da7430586b72d
https://doi.org/10.1371/journal.pone.0024413
https://doi.org/10.1371/journal.pone.0024413